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Background 
Radiotherapy is a widely-used treatment option in cancer. However, it has some associated 
problems such as increased bone metastasis after irradiation and side effects to the surrounding 
normal bone. Overexpression of periostin (POSTN) has been observed in bone metastatic cancer. 
Many studies have indicated that POSTN plays an important role in bone metastasis. However, 
the role of POSTN in the microenvironment of bone invaded by destructive cancer cells remains 
unclear. There have been few studies of the interactions between bone-invading cancer cells and 
bone matrix-forming cells after irradiation. It has been reported that expression of POSTN is 
significantly enhanced in bone tissues requiring reconstruction. High-LET radiation therapy 
induces bone hyperplasia and calcification in the irradiated area. POSTN is suspected to play an 
important role in the microenvironment of cancer bone invasion and bone tissue remodeling. 
The purpose of this study was to clarify the side effects of radiation to bone, especially the 
changes in POSTN and bone metabolism-related cytokines. 
 
Materials and Methods 
FM3A/R breast cancer cells were exposed to 0, 5, 10, or 15 Gy of gamma-ray or carbon-ion 
beam irradiation.  
1. POSTN expression in irradiated and non-irradiated control FM3A/R cells was measured by 
RT-PCR at 3 days after irradiation. MC3T3-E1 osteoblast cells were cocultured with irradiated 
and non-irradiated FM3A/R cells. The expression of receptor activator of nuclear factor kappa-B 
ligand (RANKL) and vascular endothelial growth factor (VEGF) in MC3T3-E1 cells was 
evaluated by western blotting to confirm the invasive potential of the tumor cells. To confirm the 
effect of POSTN only, MC3T3-E1 cells were cultured with recombinant POSTN-supplemented 
medium. In addition, siRNA transfection for POSTN knockdown was performed to investigate 
the influence of decreased POSTN. The expression of RANKL and VEGF in MC3T3-E1 cells 
was also measured in cells with recombinant POSTN and siRNA transfection. 
2. The time course of POSTN expression in irradiated and non-irradiated control FM3A/R cells 
was measured by RT-PCR until 7 days after irradiation. MC3T3-E1 osteoblast cells were 
cocultured with irradiated and non-irradiated control FM3A/R cells. The expression of bone 
metabolism factors osteopontin (OPN) and osterix (OSX) was evaluated by western blotting to 
evaluate the calcification potential in the microenvironment. 
 
Results 
1. POSTN expression increased after gamma-ray and carbon-ion beam irradiation. Carbon-ion 
beam-irradiated cells expressed less POSTN than gamma-ray-irradiated cells. Higher doses of 
radiation were associated with rapid increases in POSTN expression. POSTN expression in 
irradiated cells increased to higher levels than those in non-irradiated cells. Moreover, cells with 
gamma-ray irradiation expressed higher levels of POSTN than cells with carbon-ion beam 
irradiation. The expression levels of RANKL and VEGF in osteoblast cells cocultured with 
carbon-ion beam-irradiated breast cancer cells were lower than those in cells cocultured with 
gamma-ray-irradiated cells. The cytokines influencing bone invasion levels increased in tandem 
with the increase in POSTN expression. The levels of both RANKL and VEGF increased with 
the recombinant POSTN level, and the levels were similar to those in cocultures with irradiated 
breast cancer cells. POSTN synthesis was suppressed by siRNA transfection that inhibited the 
expression of RANKL and VEGF in MC3T3-E1 cells. 
2. POSTN expression increased during the time course after gamma-ray and carbon-ion beam 
irradiation. Gamma-ray-irradiated cells expressed higher levels of POSTN than carbon-ion 
beam-irradiated cells in a dose-dependent manner. Expression of OPN and OSX in MC3T3-E1 
cells cocultured with carbon-ion beam-irradiated FM3A/R cells increased in a dose-dependent 
manner until the end of the experimental period, while the expression decreased in cells 
cocultured with gamma-ray-irradiated cells.  
 
Discussion 
Carbon-ion beam irradiation was slightly superior to gamma-ray irradiation in terms of 
killing FM3A/R breast cancer cells capable of invading bone, but induced lower levels of 
POSTN synthesis than gamma-ray irradiation. Thus, carbon-ion beam irradiation may reduce the 
production of bone-destroying cytokines and vascularization factors by osteoblasts in the 
microenvironment of cancer invasion in bone. Moreover, carbon-ion beam irradiation could be a 
more effective therapy for cancers capable of invading bone, by suppressing the development of 
distant metastases. However, metastases after carbon-ion beam irradiation are still found 
clinically. To suppress the expression of POSTN in breast cancer cells after irradiation, combined 
treatment with both carbon-ion beam irradiation and POSTN inhibitor administration might 
become a treatment of choice.  
It has been inferred that POSTN in the microenvironment of bone metastatic cancer was 
produced by FM3A/R cells. High expression of POSTN after gamma-ray irradiation in FM3A/R 
cells might be a cause of metastasis and bone destruction in the bone microenvironment. In the 
case of carbon-ion beam irradiation, bone destruction and metastasis were milder compared with 
conventional gamma-ray irradiation, and it can thus be expected that the expression of 
calcification factors may increase. Further studies are required to clarify the differences in 
POSTN expression in the microenvironment arising from differences in radiation quality.  
 
Conclusion 
To suppress the expression of POSTN in breast cancer cells after radiation therapy, 
combined treatment with a POSTN inhibitor may become a treatment of choice to improve the 
bone microenvironment. 
 
 
